685 related articles for article (PubMed ID: 17060382)
1. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary ST segment evolution during primary coronary stenting predicts infarct zone recovery.
Balian V; Galli M; Repetto S; Luvini M; Galdangelo F; Castiglioni B; Boscarini M; Petrucci E; Filippini G; Marcassa C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):53-60. PubMed ID: 15619303
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
[TBL] [Abstract][Full Text] [Related]
4. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
5. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
[TBL] [Abstract][Full Text] [Related]
6. [Identification and diagnosis of myocardial damage and acute myocardial infarction during cardiopulmonary resuscitation].
Wang JG; Kong DQ; Huang Y; Huang JY; Zhang ZL; Wu WC; Pan XW
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):333-6. PubMed ID: 19570336
[TBL] [Abstract][Full Text] [Related]
7. Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention.
Ozdol C; Gulec S; Rahimov U; Atmaca Y; Turhan S; Erol C
Thromb Res; 2007; 119(4):453-9. PubMed ID: 17157900
[TBL] [Abstract][Full Text] [Related]
8. Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: impact of admission troponin T.
Bonnemeier H; Wiegand UK; Giannitsis E; Schulenburg S; Hartmann F; Kurowski V; Bode F; Tölg R; Katus HA; Richardt G
Am Heart J; 2003 Mar; 145(3):484-92. PubMed ID: 12660672
[TBL] [Abstract][Full Text] [Related]
9. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of intracoronary ST-segment shift in diagnosis of early myocardial injury during percutaneous coronary intervention].
Wang XZ; Yang ZJ; Wang YS; Zhang P; Fang YH; Li WZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):495-8. PubMed ID: 22338131
[TBL] [Abstract][Full Text] [Related]
11. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
[TBL] [Abstract][Full Text] [Related]
12. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
[TBL] [Abstract][Full Text] [Related]
13. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
[TBL] [Abstract][Full Text] [Related]
14. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
[TBL] [Abstract][Full Text] [Related]
15. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
[TBL] [Abstract][Full Text] [Related]
16. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
Brodie BR; Stuckey TD; Hansen C; VerSteeg DS; Muncy DB; Moore S; Gupta N; Downey WE
Am J Cardiol; 2005 Feb; 95(3):343-8. PubMed ID: 15670542
[TBL] [Abstract][Full Text] [Related]
17. ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarction.
Terkelsen CJ; Kaltoft AK; Nørgaard BL; Bøttcher M; Lassen JF; Clausen K; Nielsen SS; Thuesen L; Nielsen TT; Bøtker HE; Andersen HR
J Electrocardiol; 2009; 42(1):64-72. PubMed ID: 18984067
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.
Briguori C; Visconti G; Focaccio A; Golia B; Chieffo A; Castelli A; Mussardo M; Montorfano M; Ricciardelli B; Colombo A
J Am Coll Cardiol; 2009 Dec; 54(23):2157-63. PubMed ID: 19664895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
